|
|||||||||
General Information
Potential Impact of Project Results
|
EFPIA partners: . Novartis Pharma AG (project leader) . AstraZeneca AB . Bayer Pharma AG (deputy project leader) . Boehringer Ingelheim International GmbH . Esteve . GlaxoSmithKline Research and Development LTD . Janssen Pharmaceutica NV . H. Lundbeck A/S . Pfizer Limited . F. HOFFMANN-LA ROCHE AG . UCB Pharma SA . Sanofi-Aventis Deutschland GmbH . Institut de Recherches Internationales Servier
ACADEMIA partners: . Fundació Institut Mar d' Investigacions Mčdiques (project management, coordination of public partners) . Fundación Centro Nacional de Investigaciones Oncológicas Carlos III . European Molecular Biology Laboratory . Liverpool John Moores University . Technical University of Denmark . Universität Wien . VU University Amsterdam . Fraunhofer Gesellschaft zur Förderung der angewandten Forschung, Institut für Toxikologie und experimentelle Medizin . Erasmus Universitair Medisch Centrum Rotterdam . University of Leicester . Universitat Politčcnica de Valencia
SME partners: . Lhasa Limited . Inte:Ligand GmbH . Molecular Networks GmbH . Chemotargets SL . Lead Molecular Design S.L. . Synapse Research Management Partners SL
|